Adriana Skafi: Case Report on Catastrophic Antiphospholipid Syndrome
Adriana Skafi, Intern Doctor at Beit Jala Governmental Hospital, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Journal of Cardiothoracic Surgery, adding:
”Proud to share my latest peer-reviewed publication as first author:
From hemoptysis to thrombosis: a comprehensive case study of catastrophic antiphospholipid syndrome in a young female published in the Journal of Cardiothoracic Surgery
This case highlights a rare and aggressive presentation of catastrophic antiphospholipid syndrome (CAPS) with extensive thrombosis extending from the superior vena cava into the right atrium in a previously healthy young patient.
Highlighting the importance of early recognition and multidisciplinary management in rapidly progressive thrombotic disease.
Grateful for everyone involved in this work!”
Title: From hemoptysis to thrombosis: a comprehensive case study of catastrophic antiphospholipid syndrome in a young female
Authors: Adriana J. Skafi, Alaa A. Adawi, Mays Y. Butmah, Osayd Nassar, Saed Attawna,Haitham Alamlih
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 11, 2026, 04:10Haroun Gajraj: CLaCS vs Sclerotherapy – What Does the Evidence Show
-
Aug 11, 2026, 02:54Tareq Abadl: The Ultimate Guide to Clinically Significant Antibodies
-
Aug 10, 2026, 17:35Chokri Ben Lamine: Balancing Holistic Care and Precision in Hematology
-
Aug 10, 2026, 17:14Anna Stanizzi: Patient Blood Management as a New Model of Personalized Care
-
Aug 10, 2026, 17:12Odong Christopher: New Research on Ischemic Stroke Prediction in Uganda
-
Aug 10, 2026, 16:58Jeff Szer AM: Advancing the Management of Paroxysmal Nocturnal Hemoglobinuria
-
Aug 10, 2026, 16:51Suebsarn Ruksakulpiwat։ A New Milestone in the Development of the Stroke Risk Screening Scales
-
Aug 10, 2026, 16:09Preetie Shetty Akkunje: Making Stroke Rehabilitation Accessible in Low-Resource Settings
-
Aug 10, 2026, 15:50The Next Antithrombotic Frontier: GPVI Inhibitors Beyond Aspirin